Order Article Reprints

Leenhardt F, Fiteni F, Gauthier L, Alexandre M, Guiu S, Firmin N, Pouderoux S, Viala M, Lossaint G, Gautier C, et al. Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug–Drug Interactions Are the Usual Suspects. Pharmaceutics. 2022; 14(4):841. https://doi.org/10.3390/pharmaceutics14040841

Leenhardt, Fanny, Frédéric Fiteni, Ludovic Gauthier, Marie Alexandre, Séverine Guiu, Nelly Firmin, Stéphane Pouderoux, Marie Viala, Gerald Lossaint, Chloé Gautier, and et al. 2022. "Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug–Drug Interactions Are the Usual Suspects" Pharmaceutics 14, no. 4: 841. https://doi.org/10.3390/pharmaceutics14040841

Leenhardt, F., Fiteni, F., Gauthier, L., Alexandre, M., Guiu, S., Firmin, N., Pouderoux, S., Viala, M., Lossaint, G., Gautier, C., Mollevi, C., Gracia, M., Gongora, C., Mbatchi, L., Evrard, A., & Jacot, W. (2022). Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug–Drug Interactions Are the Usual Suspects. Pharmaceutics, 14(4), 841. https://doi.org/10.3390/pharmaceutics14040841